Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) Inventory
The inventory for Labcorp Holdings Inc. (LH) is $534.70 Million with a year-over-year change of +8.41%. Inventory includes raw materials, work-in-progress, and finished goods held by a company for sale or for use in production.
LH Inventory Chart
LH Inventory
$534.70M+717.58% 20Y
Zoom
Current Inventory
$534.70M
$534.70 Million
Year-over-Year Change
+8.41%
vs. $493.20M prior year
Historical Data
30
Years of data available
Annual Inventory History
| Year | Inventory | YoY Change | % Change |
|---|---|---|---|
| 2025 | $534.70M | +$41.50M | +8.41% |
| 2024 | $493.20M | +$18.60M | +3.92% |
| 2023 | $474.60M | +$4.00M | +0.85% |
| 2022 | $470.60M | +$69.20M | +17.24% |
| 2021 | $401.40M | $-21.80M | -5.15% |
| 2020 | $423.20M | +$178.50M | +72.95% |
| 2019 | $244.70M | +$7.40M | +3.12% |
| 2018 | $237.30M | +$9.70M | +4.26% |
| 2017 | $227.60M | +$22.40M | +10.92% |
| 2016 | $205.20M | +$14.20M | +7.43% |
| 2015 | $191.00M | +$51.50M | +36.92% |
| 2014 | $139.50M | +$3.00M | +2.20% |
| 2013 | $136.50M | +$15.50M | +12.81% |
| 2012 | $121.00M | +$10.20M | +9.21% |
| 2011 | $110.80M | +$7.40M | +7.16% |
| 2010 | $103.40M | +$13.40M | +14.89% |
| 2009 | $90.00M | $-1.00M | -1.10% |
| 2008 | $91.00M | +$10.60M | +13.18% |
| 2007 | $80.40M | $-3.90M | -4.63% |
| 2006 | $84.30M | +$18.90M | +28.90% |
| 2005 | $65.40M | +$3.90M | +6.34% |
| 2004 | $61.50M | +$14.50M | +30.85% |
| 2003 | $47.00M | +$2.20M | +4.91% |
| 2002 | $44.80M | +$6.10M | +15.76% |
| 2001 | $38.70M | +$7.10M | +22.47% |
| 2000 | $31.60M | +$2.50M | +8.59% |
| 1999 | $29.10M | $-1.60M | -5.21% |
| 1998 | $30.70M | $-5.30M | -14.72% |
| 1997 | $36.00M | $-8.30M | -18.74% |
| 1996 | $44.30M | — | — |
Data as of Sunday, June 14, 2026
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter